Market Research Logo

RNA Therapy Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025

RNA Therapy Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025

The report on the global RNA therapy market provides qualitative and quantitative analysis for the period from 2017 to 2025. The report predicts the global RNA therapy market to grow with a CAGR of 8.5% over the forecast period from 2019-2025. The study on RNA therapy market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.

The report on RNA therapy market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global RNA therapy market over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global RNA therapy market over the period of 2017 to 2025. Further, IGR- Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings
1) Drivers
• Rising genetic diseases, neurological disorders and viral infections
• Advancement in the sectors of molecular technology, nanotechnology and biology
2) Restraints
• High cost associated with detection kits and analytical instruments
3) Opportunities
• RNA therapy provides number of advantages over chemotherapy

Research Methodology
A) Primary Research
Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders associated with Infinium Global Research
2. Internal and External subject matter experts
3. Professionals and participants from the industry
Our primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.
B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.
The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered
The global RNA therapy market is segmented on the basis of technology, and application.

The Global RNA Therapy Market by Technology
• Enabling Technologies
• Enabled Technologies
• RNA Antisense Technologies
• RNA Interference (RNAi) Technologies

The Global RNA Therapy Market by Application
• Kidney Diseases
• Cardiovascular
• Infectious Diseases
• Oncology
• Metabolic Disorders
• Other Applications

Company Profiles
The companies covered in the report include
• Silence Therapeutics
• Cenix BioScience GmbH
• Sanofi Genzyme
• Benitec Biopharma Ltd
• Arbutus Biopharma Corporation
• DiceRNA Pharmaceuticals
• Alnylam Pharmaceuticals Inc.
• Quark Pharmaceuticals
• Other Companies

What does this report deliver?
1. Comprehensive analysis of the global as well as regional markets of the RNA therapy market.
2. Complete coverage of all the segments in the RNA therapy market to analyze the trends, developments in the global market and forecast of market size up to 2025.
3. Comprehensive analysis of the companies operating in the global RNA therapy market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. IGR- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.


The report on RNA therapy market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global RNA therapy market over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.

1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
2.1. RNA Therapy Market Highlights
2.2. RNA Therapy Market Projection
2.3. RNA Therapy Market Regional Highlights
3. Global RNA Therapy Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. IGR-Growth Matrix Analysis
3.4.1. IGR-Growth Matrix Analysis by Technology
3.4.2. IGR-Growth Matrix Analysis by Application
3.4.3. IGR-Growth Matrix Analysis by Region
3.5. Value Chain Analysis of RNA Therapy Market
4. RNA Therapy Market Macro Indicator Analysis
5. Global RNA Therapy Market by Technology
5.1. Enabling Technologies
5.2. Enabled Technologies
5.3. RNA Antisense Technologies
5.4. RNA Interference (RNAi) Technologies
6. Global RNA Therapy Market by Application
6.1. Kidney Diseases
6.2. Cardiovascular
6.3. Infectious Diseases
6.4. Oncology
6.5. Metabolic Disorders
6.6. Other Applications
7. Global RNA Therapy Market by Region 2019-2025
7.1. North America
7.1.1. North America RNA Therapy Market by Technology
7.1.2. North America RNA Therapy Market by Application
7.1.3. North America RNA Therapy Market by Country
7.2. Europe
7.2.1. Europe RNA Therapy Market by Technology
7.2.2. Europe RNA Therapy Market by Application
7.2.3. Europe RNA Therapy Market by Country
7.3. Asia-Pacific
7.3.1. Asia-Pacific RNA Therapy Market by Technology
7.3.2. Asia-Pacific RNA Therapy Market by Application
7.3.3. Asia-Pacific RNA Therapy Market by Country
7.4. RoW
7.4.1. RoW RNA Therapy Market by Technology
7.4.2. RoW RNA Therapy Market by Application
7.4.3. RoW RNA Therapy Market by Sub-region
8. Company Profiles and Competitive Landscape
8.1. Competitive Landscape in the Global RNA Therapy Market
8.2. Companies Profiles
8.2.1. Silence Therapeutics
8.2.2. Cenix BioScience GmbH
8.2.3. Sanofi Genzyme
8.2.4. Benitec Biopharma Ltd
8.2.5. Arbutus Biopharma Corporation
8.2.6. DiceRNA Pharmaceuticals
8.2.7. Alnylam Pharmaceuticals Inc.
8.2.8. Quark Pharmaceuticals
8.2.9. Other Companies
9. Appendix
9.1. Primary Research Findings and Questionnaire

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report